| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_676b80da7ac92b84e447a83fb1630ae1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7052 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa27c6db536f7e47788754770d380d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_487dd949e9e38835a3a1c13107cab67c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d131ca83bf3f18523a8e8d06c848bd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d2ca35b22b2b0fed8e4c7fc967e57f4 |
| publicationDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014176553-A1 |
| titleOfInvention |
Correctors acting through msd1 of cftr protein |
| abstract |
The present disclosure provides methods for treating Cystic Fibrosis in a subject by administering to the subject a corrector agent capable of acting through MSDl during the biosynthesis of CFTR protein. The disclosure also provides methods of screening for new corrector agents capable of acting through MSDl during the biosynthesis of a CFTR protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018081381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019136314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018201126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016105477-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017019589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019071078-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017177124-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017223188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015196071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018081378-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018081377-A1 |
| priorityDate |
2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |